XELOX (capecitabine and oxaliplatin) as 1st line treatment for elderly patients (pts) with advanced/metastatic colorectal cancer (MCRC).
暂无分享,去创建一个
J. Feliu | M. González-Barón | P. Escudero | M. Bolaños | F. Losa | A. Galán | A. Yubero | A. Salud | L. López-Gómez | J. Vicent